Castle Rock, CO, United States of America

Donna Dehn


Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2019

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Donna Dehn: Innovator in Pharmaceutical Chemistry

Introduction

Donna Dehn is a notable inventor based in Castle Rock, Colorado. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that can aid in the treatment of cancer. Her work exemplifies the intersection of innovation and healthcare, showcasing the potential of scientific research to improve patient outcomes.

Latest Patents

Donna Dehn holds a patent for "Indole derivatives and methods of using the same." This invention provides indole-4,7-dione derivatives that are useful for treating diseases in mammals. The pharmaceutical compositions derived from her research are aimed at treating cancer and neoplastic diseases, including human solid tumors and other mammalian tumors. This patent highlights her commitment to advancing medical science through innovative solutions.

Career Highlights

Dehn is affiliated with the University of Colorado, where she continues her research and development efforts. Her academic background and professional experience have positioned her as a key figure in her field. The impact of her work is evident in the potential applications of her inventions in clinical settings.

Collaborations

Some of her notable coworkers include David B. Ross and Philip Reigan. Their collaborative efforts contribute to the advancement of research and innovation in pharmaceutical applications.

Conclusion

Donna Dehn's contributions to pharmaceutical chemistry through her innovative patents demonstrate the vital role of inventors in the healthcare industry. Her work not only reflects her expertise but also holds promise for future advancements in cancer treatment.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…